help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Published ahead of print on May 3, 2007, doi:10.1164/rccm.200605-662OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200605-662OCv1
176/3/291    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auten, R. L.
Right arrow Articles by Auten, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auten, R. L.
Right arrow Articles by Auten, K. M.
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 291-299, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200605-662OC

Original Article

Inhaled Ethyl Nitrite Prevents Hyperoxia-impaired Postnatal Alveolar Development in Newborn Rats

Richard L. Auten1, Stanley N. Mason1, Mary H. Whorton1, William R. Lampe1, W. Michael Foster2, Ronald N. Goldberg1, Bo Li2, Jonathan S. Stamler2,3 and Kathryn M. Auten1

1 Division of Neonatal Medicine, Department of Pediatrics, Neonatal–Perinatal Research Institute; 2 Division of Pulmonary and Critical Care Medicine, Department of Medicine; and 3 Department of Biochemistry, Duke University Medical Center, Durham, North Carolina

Correspondence and requests for reprints should be addressed to Richard L. Auten, M.D., DUMC Box 3373, Duke University Medical Center, Durham, NC 27710. E-mail: auten{at}duke.edu

Rationale: Inhaled nitric oxide (NO) has been used to prevent bronchopulmonary dysplasia, but with variable results. Ethyl nitrite (ENO) forms S-nitrosothiols more readily than does NO, and resists higher-order nitrogen oxide formation. Because S-nitrosylation is a key pathway mediating many NO biological effects, treatment with inhaled ENO may better protect postnatal lung development from oxidative stress than NO.

Objectives: To compare inhaled NO and ENO on hyperoxia-impaired postnatal lung development.

Methods: We treated newborn rats beginning at birth to air or 95% O2 ± 0.2–20.0 ppm ENO for 8 days, or to 10 ppm NO for 8 days. Pups treated with the optimum ENO dose, 10 ppm, and pups treated with 10 ppm NO were recovered in room air for 6 more days.

Measurements and Main Results: ENO and NO partly prevented 95% O2–induced airway neutrophil influx in lavage, but ENO had a greater effect than did NO in prevention of lung myeloperoxidase accumulation, and in expression of cytokine-induced neutrophil chemoattractant-1. Treatment with 10 ppm ENO, but not NO, for 8 days followed by recovery in air for 6 days prevented 95% O2–induced impairments of body weight, lung compliance, and alveolar development.

Conclusions: Inhaled ENO conferred protection superior to inhaled NO against hyperoxia-induced inflammation. ENO prevented hyperoxia impairments of lung compliance and postnatal alveolar development in newborn rats.

Key Words: bronchopulmonary dysplasia • O-nitrosoethanol • S-nitrosylation


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
S-nitrosylation may affect a broad number of regulatory cell responses, such as inflammation. Inhaled agents that promote S-nitrosylation may provide targeted protection from inflammation.

What This Study Adds to the Field
Inhaled ethyl nitrite dose-dependently prevents hyperoxia-induced lung inflammation in newborn rats, and, at an equivalent dose, afforded better protection of postnatal lung function and development than nitric oxide.

 



This article has been cited by other articles:


Home page
 Eur Respir JHome page
W. Lenney, A. L. Boner, L. Bont, A. Bush, K-H. Carlsen, E. Eber, B. Fauroux, M. Gotz, A. Greenough, J. Grigg, et al.
Medicines used in respiratory diseases only seen in children
Eur. Respir. J., September 1, 2009; 34(3): 531 - 551.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
L. Kobzik
Translating NO Biology into Clinical Advances: Still Searching for the Right Dictionary?
Am. J. Respir. Cell Mol. Biol., July 1, 2009; 41(1): 9 - 13.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. E. Marshall, E. N. Potts, Z. T. Kelleher, J. S. Stamler, W. M. Foster, and R. L. Auten
Protection from Lipopolysaccharide-induced Lung Injury by Augmentation of Airway S-Nitrosothiols
Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 11 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. L. Auten, S. N. Mason, K. M. Auten, and M. Brahmajothi
Hyperoxia impairs postnatal alveolar epithelial development via NADPH oxidase in newborn mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2009; 297(1): L134 - L142.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
O. M. Granillo, M. V. Brahmajothi, S. Li, A. R. Whorton, S. N. Mason, T. J. McMahon, and R. L. Auten
Pulmonary alveolar epithelial uptake of S-nitrosothiols is regulated by L-type amino acid transporter
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L38 - L43.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2007
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 686 - 695.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society